Market Place
Sourcing Support
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
30 Jul 2024 //
GLOBENEWSWIRE
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
02 Apr 2024 //
GLOBENEWSWIRE
ADARx Pharma to Participate in the 44th Annual Cowen Healthcare Conference
21 Feb 2024 //
BUSINESSWIRE
ADARx Pharma to Present at the J.P. Morgan 42nd Annual Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
ADARx preps 3rd clinical program and mulls IPO
03 Oct 2023 //
FIERCE BIOTECH
RNA biotech ADARx hauls in healthy $200M series C
09 Aug 2023 //
FIERCE BIOTECH
RNA startup ADARx raises $200M from Bain, TCG to bring RNAi `to the next level`
09 Aug 2023 //
ENDPTS
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
20 Jan 2023 //
BUSINESSWIRE
ADARx Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324
20 Jan 2023 //
BUSINESSWIRE
ADARx Pharma Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as CSO
09 Jan 2023 //
BUSINESSWIRE
ADARx Appoints Feriandas Greblikas as VP of Clinical Development
18 Oct 2022 //
BUSINESSWIRE
ADARx Pharma Expands Leadership Team, Appointing Christopher Prentiss as CFO
28 Sep 2022 //
BUSINESSWIRE
ADARx Pharma Expands Leadership Team, Appoints A. Seacat as Head of Toxicology
07 Jun 2022 //
BUSINESSWIRE
ADARx Pharmaceuticals Expands Leadership Team
25 Jan 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.